These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9466675)

  • 21. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells.
    Speir E; Yu ZX; Takeda K; Ferrans VJ; Cannon RO
    Circ Res; 2000 Nov; 87(11):1006-11. PubMed ID: 11090545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased 2-methoxyestradiol production in human coronary versus aortic vascular cells.
    Zacharia LC; Jackson EK; Gillespie DG; Dubey RK
    Hypertension; 2001 Feb; 37(2 Pt 2):658-62. PubMed ID: 11230352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells.
    Christ M; Günther A; Heck M; Schmidt BM; Falkenstein E; Wehling M
    Circulation; 1999 Mar; 99(11):1485-91. PubMed ID: 10086974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle.
    Yu X; Ma H; Barman SA; Liu AT; Sellers M; Stallone JN; Prossnitz ER; White RE; Han G
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E882-8. PubMed ID: 21791623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor beta mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation.
    Watanabe T; Akishita M; Nakaoka T; Kozaki K; Miyahara Y; He H; Ohike Y; Ogita T; Inoue S; Muramatsu M; Yamashita N; Ouchi Y
    Cardiovasc Res; 2003 Sep; 59(3):734-44. PubMed ID: 14499875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoisomer-specific inhibition of superoxide anion-induced rat aortic smooth-muscle cell proliferation by 17beta-estradiol is estrogen receptor dependent.
    Cathapermal S; Lavigne MC; Leong-Son M; Alibadi T; Ramwell PW
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):499-505. PubMed ID: 9554796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of estrogen receptor subtypes alpha and beta in human aortic smooth muscle cells by oligonucleotides and estradiol.
    Barchiesi F; Jackson EK; Imthurn B; Fingerle J; Gillespie DG; Dubey RK
    J Clin Endocrinol Metab; 2004 May; 89(5):2373-81. PubMed ID: 15126566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic and proliferative responses to estrogen by hepatocytes selected for plasma membrane binding-sites specific for estradiol-17beta.
    Pietras RJ; Szego CM
    J Cell Physiol; 1979 Jan; 98(1):145-59. PubMed ID: 368082
    [No Abstract]   [Full Text] [Related]  

  • 29. Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries.
    Traupe T; Stettler CD; Li H; Haas E; Bhattacharya I; Minotti R; Barton M
    Hypertension; 2007 Jun; 49(6):1364-70. PubMed ID: 17470727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle.
    Tharp DL; Wamhoff BR; Turk JR; Bowles DK
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2493-503. PubMed ID: 16798818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs.
    Barchiesi F; Jackson EK; Gillespie DG; Zacharia LC; Fingerle J; Dubey RK
    Hypertension; 2002 Apr; 39(4):874-9. PubMed ID: 11967242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation.
    Geraldes P; Sirois MG; Tanguay JF
    Circ Res; 2003 Sep; 93(5):399-405. PubMed ID: 12893737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells.
    Takahashi K; Ohmichi M; Yoshida M; Hisamoto K; Mabuchi S; Arimoto-Ishida E; Mori A; Tsutsumi S; Tasaka K; Murata Y; Kurachi H
    J Endocrinol; 2003 Aug; 178(2):319-29. PubMed ID: 12904179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms.
    Dubey RK; Gillespie DG; Zacharia LC; Rosselli M; Korzekwa KR; Fingerle J; Jackson EK
    Biochem Biophys Res Commun; 2000 Nov; 278(1):27-33. PubMed ID: 11071850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The response of smooth muscle cells to alpha-thrombin depends on its arterial origin: comparison among different species.
    Varela O; Martínez-González J; Badimon L
    Eur J Clin Invest; 1998 Apr; 28(4):313-23. PubMed ID: 9615911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-beta.
    Maggi A; Cignarella A; Brusadelli A; Bolego C; Pinna C; Puglisi L
    Circulation; 2003 Jul; 108(2):211-7. PubMed ID: 12821541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries.
    Eid AH; Maiti K; Mitra S; Chotani MA; Flavahan S; Bailey SR; Thompson-Torgerson CS; Flavahan NA
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1955-61. PubMed ID: 17644575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human recombinant insulin-like growth factor I and -II stimulate the expression of basic fibroblast growth factor but suppress the division of bovine coronary smooth muscle cells.
    Schriever C; Schmidt A; Breithardt G; Buddecke E
    Atherosclerosis; 1996 May; 122(2):255-63. PubMed ID: 8769688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Methoxyestradiol and analogs as novel antiproliferative agents: analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding.
    Hughes RA; Harris T; Altmann E; McAllister D; Vlahos R; Robertson A; Cushman M; Wang Z; Stewart AG
    Mol Pharmacol; 2002 May; 61(5):1053-69. PubMed ID: 11961123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells.
    Kim-Schulze S; McGowan KA; Hubchak SC; Cid MC; Martin MB; Kleinman HK; Greene GL; Schnaper HW
    Circulation; 1996 Sep; 94(6):1402-7. PubMed ID: 8822999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.